QUEST informs readers of the latest advances in urologic prostate cancer research, especially detection, prevention, and treatment.

3men younger

Postoperative Treatment After A Radical Prostatectomy

Doctors and patients alike hope that removing the prostate, a radical prostatectomy (RP), will be a successful, life-long treatment for prostate cancer. Still, patients need to be informed of recommended further testing after the surgery and preventative postoperative treatments connected…

Read More

Proscar Is In the News: Dr. Catalona Responds

RISK USING PROSCAR OR PROPECIA Q: What information do you have regarding the increased risk of high grade prostate cancer when taking Proscar or Propecia (finasteride)? A: Proscar is in the family of drugs commonly used to treat or prevent…

Read More
blood samples

Blood and Tissue Samples

Why They Are So Important to Dr. Catalona Blood and tissue samples from patients serve at least two purposes. One is to help with the diagnosis and treatment for a particular patient. The PSA test (from a blood sample) and…

Read More

PIN and Prostate Cancer: New Studies Show Less Risk

PIN (prostatic intraepithelial neoplasia), a microscopic finding reported in 5% to 10% of prostate biopsies, has been regarded as a red flag suggesting the possible presence of cancer. However, in recent years, some research groups have found that men who…

Read More
nw research teamA

PSA Screening: It’s A Must

Prostate cancer has no known means of prevention and no known cure for advanced-stage disease; therefore, the only method for reducing the mortality and morbidity from prostate cancer is to detect it early and treat it effectively. Screening with prostate-specific…

Read More
catalona gB sM

Pro-PSA: Possibly a Better Marker for Prostate Cancer

PSA testing has revolutionized the early diagnosis and treatment of prostate cancer. Increasing evidence shows that PSA testing is also responsible for the decreasing prostate cancer death rates occurring in the US and other countries. In the US alone, since…

Read More

Subscribe to Quest

"*" indicates required fields

Email

This email address is only for subscribing or unsubscribing to or from Quest. Dr. Catalona cannot respond to questions concerning your Personal Health Information (PHI) that could identify you as an individual. This is a "cyber-security measure" for your protection that will help prevent anyone from legally or illegally accessing your personal health information.

Delivery Method (How do you want to receive your Quest publication?)*
Address*